Related Experiment Videos
Comment on: "Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes"
Antonio Pires1, Kavitha Goyal1, Andrew Greenspan2
1Janssen Pharmaceuticals, 800 Ridgeview Drive, Horsham, PA, 19044, USA.
Drugs
|May 23, 2018
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Coronary-Sparing Resection of a Pediatric Left Ventricular Fibroma Involving the Left Circumflex Artery: Six-Year Follow-Up.
World journal for pediatric & congenital heart surgery·2026
Percutaneous closure of a large left main coronary artery fistula in a paediatric patient.
Cardiology in the young·2025
Do Seaweeds Contribute to Nutritional Composition and Acceptance in Traditional Portuguese Recipes?
Foods (Basel, Switzerland)·2025
Guselkumab binding to CD64+ IL-23-producing myeloid cells enhances potency for neutralizing IL-23 signaling.
Frontiers in immunology·2025
A "hybrid" approach to total anomalous pulmonary venous return repair.
Cardiology in the young·2025
Veligrotug: First Approval.
Drugs·2026
Ruzinurad: First Approval.
Drugs·2026
Mechanical circulatory support devices in heart failure: a narrative review of current evidence, clinical applications, complications, and future directions.
Frontiers in cardiovascular medicine·2026
Pharmacotherapy for MASLD/MASH: approved therapies, drug repurposing, and emerging mechanism-based candidates.
Expert opinion on pharmacotherapy·2026
Effectiveness and safety of three years of bulevirtide monotherapy in patients with HDV-related compensated cirrhosis: the Italian compassionate use program.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2026
Long-term outcomes of alemtuzumab in relapsing-remitting multiple sclerosis: a real-world cohort with particular focus on treatment sequencing after natalizumab.
Journal of the neurological sciences·2026